| Toll-like receptor 4 is a sensor for autophagy associated with innate immunity YI Xu, C Jagannath, XD Liu, A Sharafkhaneh, KE Kolodziejska, NT Eissa Immunity 27 (1), 135-144, 2007 | 1041 | 2007 |
| Association of psychiatric disorders and sleep apnea in a large cohort A Sharafkhaneh, N Giray, P Richardson, T Young, M Hirshkowitz Sleep 28 (11), 1405-1411, 2005 | 600 | 2005 |
| Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort NA Hanania, H Müllerova, NW Locantore, J Vestbo, ML Watkins, ... American journal of respiratory and critical care medicine 183 (5), 604-611, 2011 | 462 | 2011 |
| A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial VS Fan, JM Gaziano, R Lew, J Bourbeau, SG Adams, S Leatherman, ... Annals of internal medicine 156 (10), 673-683, 2012 | 449 | 2012 |
| Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort H Müllerova, DJ Maselli, N Locantore, J Vestbo, JR Hurst, JA Wedzicha, ... Chest 147 (4), 999-1007, 2015 | 403 | 2015 |
| Airway mucus: from production to secretion OW Williams, A Sharafkhaneh, V Kim, BF Dickey, CM Evans American journal of respiratory cell and molecular biology 34 (5), 527-536, 2006 | 364 | 2006 |
| Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression JA Cully, DP Graham, MA Stanley, CJ Ferguson, A Sharafkhaneh, ... Psychosomatics 47 (4), 312-319, 2006 | 363 | 2006 |
| Prevalence, predictors and economic consequences of no-shows P Kheirkhah, Q Feng, LM Travis, S Tavakoli-Tabasi, A Sharafkhaneh BMC health services research 16, 1-6, 2015 | 349 | 2015 |
| Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised … EFM Wouters, DS Postma, B Fokkens, WCJ Hop, J Prins, AF Kuipers, ... Thorax 60 (6), 480-487, 2005 | 331 | 2005 |
| COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial ME Kunik, C Veazey, JA Cully, J Souchek, DP Graham, D Hopko, ... Psychological medicine 38 (3), 385-396, 2008 | 281 | 2008 |
| Pathogenesis of emphysema: from the bench to the bedside A Sharafkhaneh, NA Hanania, V Kim Proceedings of the American Thoracic Society 5 (4), 475-477, 2008 | 269 | 2008 |
| Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology JC Hogg, FSF Chu, WC Tan, DD Sin, SA Patel, PD Pare, FJ Martinez, ... American journal of respiratory and critical care medicine 176 (5), 454-459, 2007 | 263 | 2007 |
| Risk indexes for exacerbations and hospitalizations due to COPD DE Niewoehner, Y Lokhnygina, K Rice, WG Kuschner, A Sharafkhaneh, ... Chest 131 (1), 20-28, 2007 | 259 | 2007 |
| Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications H Qureshi, A Sharafkhaneh, NA Hanania Therapeutic advances in chronic disease 5 (5), 212-227, 2014 | 238 | 2014 |
| Oxygen therapy in chronic obstructive pulmonary disease V Kim, JO Benditt, RA Wise, A Sharafkhaneh Proceedings of the American Thoracic Society 5 (4), 513-518, 2008 | 217 | 2008 |
| Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease JH Yun, A Lamb, R Chase, D Singh, MM Parker, A Saferali, J Vestbo, ... Journal of allergy and clinical immunology 141 (6), 2037-2047. e10, 2018 | 209 | 2018 |
| Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study A Sharafkhaneh, JG Southard, M Goldman, T Uryniak, UJ Martin Respiratory medicine 106 (2), 257-268, 2012 | 173 | 2012 |
| A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation CCTWGRG Barr, EA Berkowitz, F Bigazzi, F Bode, J Bon, RP Bowler, ... COPD: Journal of Chronic Obstructive Pulmonary Disease 9 (2), 151-159, 2012 | 171 | 2012 |
| β-Agonist Intrinsic Efficacy: Measurement and Clinical Significance NA Hanania, A Sharafkhaneh, R Barber, BF Dickey American journal of respiratory and critical care medicine 165 (10), 1353-1358, 2002 | 137 | 2002 |
| The asthma COPD overlap syndrome (ACOS) S Bujarski, AD Parulekar, A Sharafkhaneh, NA Hanania Current allergy and asthma reports 15, 1-9, 2015 | 114 | 2015 |
